The most puzzling fact about ZBTB7A mutations in AML is their exclusive presence in the context of core binding factor leukemia, mainly in t(8;21) AML [1–6], which suggests a specific collaboration between RUNX1–RUNX1T1 and loss of ZBTB7A function. This evidence concerns the gene RUNX1 and acute myeloid leukemia.